JOEMX
Price
$11.28
Change
-$0.10 (-0.88%)
Updated
Sep 6 closing price
RNWFX
Price
$79.55
Change
-$1.12 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

JOEMX vs RNWFX

Header iconJOEMX vs RNWFX Comparison
Open Charts JOEMX vs RNWFXBanner chart's image
JOHCM Emerging Markets Opps Instl
Price$11.28
Change-$0.10 (-0.88%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$79.55
Change-$1.12 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
JOEMX vs RNWFX Comparison Chart
Loading...
VS
JOEMX vs. RNWFX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JOEMX is a StrongSell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.1B vs. JOEMX (1.07B). JOEMX pays higher dividends than RNWFX: JOEMX (1.69) vs RNWFX (1.51). JOEMX was incepted earlier than RNWFX: JOEMX (12 years) vs RNWFX (22 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. JOEMX (29.34). RNWFX has a lower initial minimum investment than JOEMX: RNWFX (250) vs JOEMX (100000). RNWFX annual gain was more profitable for investors over the last year : 11.53 vs. JOEMX (7.64). RNWFX return over 5 years is better than : 22.38 vs. JOEMX (19.90).
JOEMXRNWFXJOEMX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years22 years-
Gain YTD4.3287.24560%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B60.1B2%
Annual Yield % from dividends1.691.51112%
Returns for 1 year7.6411.5366%
Returns for 3 years-8.83-15.4457%
Returns for 5 years19.9022.3889%
Returns for 10 years14.3735.7140%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EGO16.410.29
+1.80%
Eldorado Gold Corp
BIP31.38-0.08
-0.25%
Brookfield Infrastructure Partners LP
KTRA0.17N/A
-2.51%
Kintara Therapeutics
LCTX0.87-0.03
-3.17%
Lineage Cell Therapeutics
NUVB2.88-0.13
-4.32%
Nuvation Bio